Smith Jason Drew

Related Filers (1)

Other (1)

144
Thursday, 2/1/2024
Filing for proposed sale of securities under Rule 144
Show More

Ownership (14)

4/A
Monday, 2/5/2024
UroGen Pharma Ltd.: Statement of changes in beneficial ownership of securities
4
Friday, 2/2/2024
UroGen Pharma Ltd.: Statement of changes in beneficial ownership of securities
4
Friday, 9/8/2023
UroGen Pharma Ltd.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/5/2023
UroGen Pharma Ltd.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/2/2023
UroGen Pharma Ltd.: Statement of changes in beneficial ownership of securities
4
Friday, 9/2/2022
UroGen Pharma Ltd.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/2/2022
UroGen Pharma Ltd.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/2/2021
UroGen Pharma Ltd.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/8/2021
UroGen Pharma Ltd.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/18/2021
UroGen Pharma Ltd.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/2/2021
UroGen Pharma Ltd.: Statement of changes in beneficial ownership of securities
4/A
Monday, 10/5/2020
UroGen Pharma Ltd.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/10/2020
UroGen Pharma Ltd.: Statement of changes in beneficial ownership of securities
3
Thursday, 9/10/2020
UroGen Pharma Ltd.: Initial statement of beneficial ownership of securities
Show More